Abstract
This report describes a clinical case that supports the hypothesis that occult bone marrow disease may exist even in early-stage and low prostate-specific antigen (less than 10 ng/mL) prostate cancer. The concept of adding androgen suppression to definitive local therapy in these patients is discussed.
MeSH terms
-
Aged
-
Bone Marrow / metabolism*
-
Bone Marrow Cells
-
Bone Marrow Neoplasms / metabolism
-
Bone Marrow Neoplasms / pathology
-
Bone Marrow Neoplasms / secondary
-
Humans
-
Male
-
Neoplasm Staging
-
Prostate-Specific Antigen / biosynthesis*
-
Prostatic Neoplasms / metabolism*
-
Prostatic Neoplasms / pathology
Substances
-
Prostate-Specific Antigen